Ahmet Beyazıt — Endo Lab

article 2026

Terazosin as a Non-Hormonal Treatment for Endometriosis

International journal of molecular sciences ·doi:10.3390/ijms27094093

Endometriosis is a chronic, estrogen-dependent inflammatory disease including aberrant local steroidogenesis, inflammation, angiogenesis, oxidative stress, and prostaglandin-mediated pain. Given the elevated adrenergic receptor expression i…

dataset 2026

Terazosin Suppresses Endometriosis Progression via Downregulation of Steroidogenic Factor-1: An Experimental Rat Model

·doi:10.17632/c2ybb3kzdf.1

This dataset contains the raw biochemical, molecular, data and statistics from an in vivo experimental study evaluating the therapeutic efficacy of terazosin, an alpha-1 adrenergic receptor antagonist, in a surgically induced rat model of e…

dataset 2026

Terazosin Suppresses Endometriosis Progression via Downregulation of Steroidogenic Factor-1: An Experimental Rat Model

·doi:10.17632/c2ybb3kzdf

This dataset contains the raw biochemical, molecular, data and statistics from an in vivo experimental study evaluating the therapeutic efficacy of terazosin, an alpha-1 adrenergic receptor antagonist, in a surgically induced rat model of e…

2026

Urological Injuries Following Gynecologic and Obstetric Surgery: Incidence, Diagnosis, and Outcomes from a 10-Year Retrospective Cohort.

Healthcare (Basel, Switzerland) ·doi:10.3390/healthcare14030327

Background/objectivesGynecological and obstetric surgeries carry a risk of iatrogenic urinary tract injuries; however, comparative data on injury patterns, diagnostic timing, and management across different surgical indications remain limit…